Hyperpigmentation Disorder Treatment Market Size was valued at USD 6.98 Bn in 2023 and is predicted to reach USD 12.54 Bn by 2031 at a 7.8% CAGR during the forecast period for 2024-2031.
Hyperpigmentation disorder treatment issues can be treated with a combination of medical treatments and cosmetic operations that attempt to lessen the appearance and severity of hyperpigmented skin. The rising number of cases of hyperpigmentation disorder treatment, the need for novel treatments, and the development of more effective lasers are all factors that should lead to expansion in the hyperpigmentation disorder treatment market. In addition, the market is growing because people are becoming more aware of pigmentation problems, which is driving up the demand for safe and effective treatments. In addition, the projection period for the hyperpigmentation disorder treatment market is anticipated to be filled with attractive potential driven by the increased demand for outpatient and microsurgical procedures.
However, the market growth is hampered by the absence of knowledge requirements for the safety and health of hyperpigmentation disorder treatment, stringent regulatory standards, and the high cost of hyperpigmentation disorder treatment. Companies in the global hyperpigmentation disorder treatment market are finding profitable prospects due to technological improvements in cosmeceuticals and the accompanying increase in skincare products using cosmeceuticals. So that they can increase their market share, major companies are pouring money into nanotechnology research and development. Furthermore, an increasing number of individuals are seeking professional treatment for hyperpigmentation as a result of better access to healthcare, particularly in emerging nations.
The hyperpigmentation disorder treatment market is segmented based on treatment type, condition, and end user. Based on treatment type, the market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. By condition, the market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. By end user, the market is segmented into hospitals, dermatology centers, and others.
Laser therapy is expected to hold a major global market share in 2023 because it is generally considered to be an excellent strategy for decreasing hyperpigmentation. Due to ever-improving laser technology, these treatments are now safer, more effective, and can be used on a broader variety of skin types. Laser therapy for hyperpigmentation disorder treatment has also seen increased uptake from both patients and doctors as word of its efficacy spreads.
The dermatology segment is growing in the hyperpigmentation disorder treatment market because dermatologists best manage hyperpigmentation disorders due to their extensive training concerning the examination and care of skin disorders. Dermatologists are seeing an increase in patients as more people learn about the need for skin health and the benefits of early treatment for hyperpigmentation. Hyperpigmentation disorder concerns are becoming more common, which is leading to a desire for dermatological care that is specialized.
The North American hyperpigmentation disorder treatment market is expected to register the highest market share in revenue in the near future. It can be attributed to the highly developed healthcare system, remarkable dermatological technology, a robust healthcare system, and a high level of public understanding regarding skin care and aesthetic procedures. In addition, Asia Pacific is projected to grow rapidly in the global hyperpigmentation disorder treatment market due to the fact that, as the population grows, more individuals will require healthcare access. The incidence of age-related hyperpigmentation is on the rise because of the growing elderly population in the region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 6.98 Bn |
|
Revenue Forecast In 2031 |
USD 12.54 Bn |
|
Growth Rate CAGR |
CAGR of 7.8% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Treatment Type, By Condition, By End-user and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
AbbVie Inc, Bayer AG, Epipharm AG, Galderma Laboratories, Obagi Cosmeceuticals LLC, Lutronic Corporation, La Pristine, L’oreal S.A, Pierre Fabre Group, and Vivier Pharma USA. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Hyperpigmentation Disorder Treatment Market Snapshot
Chapter 4. Global Hyperpigmentation Disorder Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Treatment Type Estimates & Trend Analysis
5.1. by Treatment Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Treatment Type:
5.2.1. Cosmeceutical
5.2.2. Light or Laser Therapy
5.2.3. Microdermabrasion
5.2.4. Chemical Peels
5.2.5. Cryotherapy
5.2.6. Others
Chapter 6. Market Segmentation 2: by Condition Estimates & Trend Analysis
6.1. by Condition & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Condition:
6.2.1. Melasma
6.2.2. Solar Lentigines
6.2.3. Post-Inflammatory Hyperpigmentation
6.2.4. Others
Chapter 7. Market Segmentation 3: by End-User Estimates & Trend Analysis
7.1. by End-User & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
7.2.1. Hospitals
7.2.2. Dermatology Centers
7.2.3. Others
Chapter 8. Hyperpigmentation Disorder Treatment Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.1.2. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.1.3. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.1.4. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.2.2. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.2.3. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.2.4. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.3.2. Asia Pacific Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.3.3. Asia Pacific Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.3.4. Asia Pacific Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.4.2. Latin America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.4.3. Latin America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.4.4. Latin America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.5.2. Middle East & Africa Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.5.3. Middle East & Africa Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.5.4. Middle East & Africa Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AbbVie Inc,
9.2.2. Bayer AG,
9.2.3. Epipharm AG,
9.2.4. Galderma Laboratories,
9.2.5. Obagi Cosmeceuticals LLC,
9.2.6. Lutronic Corporation,
9.2.7. La Pristine,
9.2.8. L?oreal S.A,
9.2.9. Pierre Fabre Group,
9.2.10. Vivier Pharma USA
9.2.11. Other Prominent Players
Hyperpigmentation Disorder Treatment Market- By Treatment Type
Hyperpigmentation Disorder Treatment Market- By Condition
Hyperpigmentation Disorder Treatment Market- By End User
Hyperpigmentation Disorder Treatment Market- By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
